| Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial | Clinical Microbiology and Infection |  | | 2020 | 337 | 259 |
|
| Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial | Clinical Infectious Diseases | | | 2019 | 329 | 379 |
|
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease |  | | 2018 | 595 | 0 |
|
| Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study | BMC Infectious Diseases | | | 2018 | 547 | 320 |
|
